Aethlon Medical
AEMD
8 hedge funds and large institutions have $1.51M invested in Aethlon Medical in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 4 → 8 (+4)
54% more capital invested
Capital invested by funds: $975K → $1.51M (+$531K)
1.87% more ownership
Funds ownership: 5.69% → 7.56% (+1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$265K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$177K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$88.4K |
| 4 |
SAM
Shamrock Asset Management
Dallas,
Texas
|
+$88.4K |
| 5 |
VF
Virtu Financial
New York
|
+$88.4K |
Top Sellers
AEMD Hedge Fund Activity: Q1 2018 in Review
8 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2018, worth a combined $1.51M — up 54% from $975K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AEMD positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $265K.
- 8 institutional investors held Aethlon Medical (AEMD) as of Q1 2018, up from 4 in Q4 2017.
- Funds reported $1.51M of Aethlon Medical stock for Q1 2018, up 54% quarter-over-quarter.
- 4 funds opened new Aethlon Medical positions in Q1 2018 and 0 closed out, a net change of +4 holders.
- The largest Aethlon Medical buyer in Q1 2018 was Millennium Management, an estimated $265K added.
Based on aggregated 13F filings for Q1 2018.